This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Hydromorphone Hydrochloride Injection USP HP 10 (2017-07-26)
- Starting date:
- July 26, 2017
- Posting date:
- August 2, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-64096
Reason
Affected lot contaminated with silicone particulate
Depth of distribution
Wholesalers and hospitals across Canada
Affected products
Hydromorphone Hydrochloride Injection USP HP 10
DIN, NPN, DIN-HIM
DIN 02382636
Dosage form
Solution
Strength
10 mg/mL
Lot or serial number
56261DD
Companies
- Recalling Firm
-
Hospira Healthcare Corporation
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
- Marketing Authorization Holder
-
Hospira Healthcare Corporation
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA